BIO-TECHNE Corp — Director's Dealing 2010

Nov 4, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2010-11-02

Reporting Person: VERONNEAU MARCEL (VP Hematology Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-02	Common Stock	F	4520	$61.31	Disposed	27080	Direct
2010-11-02	Common Stock	M	7489	$37.011	Acquired	34569	Direct
2010-11-03	Common Stock	M	7511	$37.011	Acquired	42080	Direct
2010-11-03	Common Stock	S	7511	$61.08	Disposed	34569	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-11-02	Stock Option	$37.011	M	7489	Disposed	2010-11-30	Common Stock (7489)	Direct
2010-11-03	Stock Option	$37.011	M	7511	Disposed	2010-11-30	Common Stock (7511)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6702	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$58.4	2017-07-29	Common Stock (1281)	1281	Direct
Stock Option	$66.25	2017-04-29	Common Stock (10000)	10000	Direct
Stock Option	$62.46	2016-07-23	Common Stock (494)	494	Direct
Stock Option	$79.41	2015-07-24	Common Stock (385)	385	Direct
Stock Option	$56.83	2014-07-26	Common Stock (510)	510	Direct
Stock Option	$49.43	2013-07-27	Common Stock (567)	567	Direct
Stock Option	$51.6	2012-08-17	Common Stock (475)	475	Direct
Stock Option	$40.47	2011-07-08	Common Stock (505)	505	Direct

Footnotes

F1: Vested 5000 each 4/30/11 and 4/30/12